Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
formulary
Payers
Why payers should have these 3 pipeline drugs on their radar
Optum Rx's latest look at the drug development pipeline highlights three drugs for rare and chronic conditions.
Paige Minemyer
Aug 3, 2026 3:38pm
Fierce Pharma
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
May 28, 2026 11:20am
CalPERS swaps OptumRx for Caremark in risk-based PBM contract
Jul 15, 2025 4:52pm
CMS rolls out generic drug list to ease cost-sharing burden
Oct 9, 2024 10:30am
Health Affairs study tracks buprenorphine coverage by payer type
May 2, 2023 4:15pm
